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Özet
Amaç: Tansiyonu normal olan üreme çağındaki polikistik over sendromlu 
(PKOS) kadınlarda sağ ve sol böbrek uzunluğu, parankim kalınlığı, renal arte-
riyel, venöz kan akımı ölçümlerinde farklılık olup olmadığını araştırmak. Gereç 
ve Yöntem: Rotterdam kriterlerine göre PKOS tanısı almış 40 kadın olgu ve 36 
sağlıklı kadın olgu çalışmaya dahil edildi. Hormonal, biyokimyasal analiz, renal 
Doppler ultrasonografi yapıldı, sağ ve sol böbrek uzunluğu, parankim kalınlığı, 
pik sistolik velosite (PSV), rezistiv indeks (RI) ,venöz impedans indeksi(VI), in-
sülin rezistansı, bozulmuş glikoz toleransı, serum lipid konsantrasyonu araştı-
rıldı. Student t testi ve pearson korelasyon testi istatistik analiz için kullanıl-
dı. Bulgular: Böbreklerin ölçümleri açısından PKOS’lu ve sağlıklı kadınlar ara-
sında fark yoktu. Ana renal arterin pik sistolik velositesi PKOS’lu grupta daha 
düşüktü. Ana renal venöz impedans PKOS’lu grupta kontrol grubundan daha 
yüksekti. Ana renal rezistif indeks PKOS’lu grupta daha yüksekti, fakat istatis-
tiksel olarak önemli değildi. Tüm olguları içeren bivariate analizde, ana böb-
rek uzunluğu, ana parankim kalınlığı ölçümleri ile BMI, bel kalça oranı, serum 
açlık glikoz, insülin, LDL, tirgliserit seviyeleri pozitif ilişkiliydi. Tartışma: Biz 
PKOS’lu normotansif üreme çağındaki kadınlarda böbrek kan akımında deği-
şiklikler olduğunu bulduk . Bu bulgular PKOS’un uzun önem renal ve kardiyo-
vasküler komplikasyonlarının sonucunu gösteriyor olabilir. 
Anahtar Kelimeler
Doppler Ultrasonografi; Polikistik Over Sendromu
Abstract
Aim: To investigate whether there is alteration both right and left kidney 
lenght, parenchymal thickness, renal arterial,venous blood flow measure-
ments in normotensive reproductive age women with polycystic ovary syn-
drome (PCOS). Material and Method: Forty women with PCOS according to 
Rotterdam criteria and thirty-six healthy volunteers women were included 
in our study. Hormonal, biochemical analysis, renal Doppler ultrasonography 
were performed and were investigated in terms of both left and right renal 
lenght, parenchymal thickness, peak systolic velocity (PSV), resistive index 
(RI), venous impedance index (VI), metabolic characteristics having insulin 
resistance, impaired glucose tolerance, serum lipid concentration. The stu-
dent t test and pearson corelation test were used for statistical analysis.
Results: The measurements for kidneys were not different between women 
with PCOS and healthy women. The peak systolic velocity of mean renal ar-
tery was lower in PCOS group. The mean renal venous impedance also was 
higher in PCOS group than control group. The mean renal resistive index was 
slightly higher in PCOS but not statistical significant. In bivariate corelation 
analyse including all patients, it was seen that BMI, WHR, level of serum 
fasting glucose, insulin, LDL, trigliserides were positively related with mean 
renal length and mean parenchymal thickness measurements. Discussion: We 
found that there was alterations kidney blood flow in normotensive reproduc-
tive age women with PCOS. This findings may indicate results of long term 
renal and cardiovascular complications of PCOS. 
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Introduction
Polycystic ovary syndrome (PCOS) is one of the most com-
mon endocrinopathies in women of fertile age and affects up 
to 6–7% of this population [1] . Using the Rotterdam consen-
sus criteria could increase the prevalence of PCOS by at least 
65%. PCOS according to Rotterdam consensus criteria should 
be defined by the presence of at least three to two (1- chronic 
anovulation 2-clinical and/or biochemical hyperandrogenism 
3- polycystic ovaries on ultrasound) with the exclusion of other 
androgen excess or related disorders [2]. It has been recognized 
that PCOS is associated with metabolic abnormalities such as 
insulin resistance, dyslipidemia, chronic low-grade inflamma-
tion, and arterial hypertension[3]. Recently, most studies have 
linked PCOS with a potentially increased risk of cardiovascular 
disease [4]. 
Hypertension has a high prevalence in woman with PCOS in the 
perimenopausal period. Metabolic disturbances is expected to 
be less common in the phenotypically heterogenous group of 
PCOS patients diagnosed by Rotterdam criteria.
Overall, of major concern is to what extent the PCOS-related 
metabolic abnormalities translate into increased cardiovascu-
lar (CV) morbidity and mortality in these women. Recent data 
in postmenopausal women show that PCOS is associated with 
an increased rate of CV events, which is partly independent of 
the presence of obesity, diabetes and MS, and partly dependent 
on the degree of hyperandrogenemia [5] Thus, the burdens of 
CV risk conferred by PCOS and by MS, respectively, appear to 
be not identical, but additive. PCOS emerges as an independent 
predictor of CV complications after menopause. 
PCOS long term consequence lead to hypertension, atheroscle-
rosis, proteinuria. It was reported previously that first finding of 
impared renal function was variance of renal hemodinamics [6]. 
As is known, B-mode ultrasonography is stil first radiologic 
method in the evaluation of native renal dysfunction. Renal 
length, cortical thickness and parenchymal echogenicity and 
collecting system dilatation are examined. In spite of these 
parameters correlate well with hystopathology, usually, these 
values may help in assesment disease chronicity rather than 
hystopathology[7]. Since 1980-1990 years, renal Doppler so-
nography has been used primarily for the screening of renovas-
cular disease in native and transplant kidneys [8] . 
Doppler sonography is a nonivasive method of evaluation of lo-
cal vascular resistance, such as resistance index [RI). Especially, 
renal RI values are useful for the assesment of renal paren-
chymal damage and may provide a reliable parameter of renal 
atherosclerosis [9]. In addition, RI values of intrarenal arteries 
gives information about severity of target organ damage in 
diseases as hypertension, diabetes mellitus and chronic renal 
failure [10].
The purpose of the present cross sectional case-control study 
was to compare between women with PCOS and healthy con-
trol and make correlations the Doppler parameters of renal ar-
tery, the interlobar arteries, renal vein including synchronously 
obtained serum glucose, insulin, lipid levels, other parameters. 
Material and Method
In this study, after the evaluation of medical history, physical /
gynecologycal examination and transvaginally ultrasonography 
was performed. The diagnosis of PCOS was made according to 
the criteria of the Rotterdam ESHRE ASRM- sponsored PCOS 
consensus workshop group (2004) where 2 out of 3 criteria 
were present: 1- oligo and/or anovulation (menstrual cycle be-
tween 35-50 days or secondary amenorrhea and/or anovula-
tion); 2- clinic and/or biochemical signs of hyperandrogenism 
[Ferriman-Gallway modified score ≥8 and/or acne, and /or hy-
perandrogenemia: total testosterone (T) >0,6 ng/ml (2 nmol/l); 
3- polycystic ovaries (PCO), identified by transvaginal ultraso-
nography (presence of ≥12 follicles in each ovary, measuring 
2-9 mm in diameter and/or increased ovarian volume>10cm³) 
[2]. 
This study was approved by Baskent University Institutional Re-
view Board and Ethics Committee (Project no: KA09/262) and 
supported by Baskent University Research Fund. After receiving 
local ethical approval, written informed consent was obtained 
from all patients before enrollment. Patients had no pregnancy. 
None of the patients had any other chronic kidney, systemic, 
endocrin disease such as Type 2 Diabetes mellitus or hyper-
tension, the basis of clinical history and physical examination, 
routine blood tests. None of the patients had pharmacological 
treatment for PCOS-related disorders, including oral contrasep-
tive, antiandogenic drugs, insulin sensitizer drugs, antiplatelet 
drugs. Smoking patients were excluded. Clinic blood pressure 
(BP) measurements were performed with a mercury phygmo-
manometer. Patients having hypertension is defined as systolic 
BP greater than 140 mm Hg and/or diastolic BP greater than 
90 mm Hg were not included in the study. Women having pre-
vious history of kidney stone, kidney operation, pregnancy in-
duced hypertention were excluded.
Ultrasonography was performed by 6,5mHz micro-convex 
transvaginal probe (Voluson 730 Pro, General Electric Co,USA). 
Ultrasound examination was carried out on second or thirth day 
of natural menses. Follicle which is smaller than 10mm diame-
ter was countered. Antral follicle count (AFC) were recorded to-
tally for both ovary. Hormone profile ( luteinizing hormone (LH), 
Total testosterone, free tetosterone, tiroid stimulan hormone 
(TSH), insulin), and biochemistry profile (Fasting Glucose, HDL, 
LDL, Triglyceride, OGTT (75g)) were performed on the same day 
with ultrasound evaluation. Renal Doppler evaluation was also 
performed on the same day with other procedurs. 
Anthropometric measurements were obtained at the umbilicus 
(waist circumference) and at the most prominent buttock level 
(hip circumference); their ratio (waist-to-hip ratio, WHR) was 
considered as a measure of body fat distribution. Insulin resis-
tance was calculated using the HOMA index. HOMA index was 
calculated as: [fasting plasma insulin (μU/ml) × fasting plasma 
glucose (mmol/l)]/ 22.5. As we obtained glucose levels in g/dl, 
we had to multiply our data by 0.055 to change them to mmol/l 
for the calculation of HOMA index [11]. 
Laboratory Analysis
A blood venous sample was obtained after an overnight fasting 
to assess biochemical data.
Fasting glucose, high-density lipoprotein (HDL) cholesterol, 
low-density lipoprotein (LDL) cholesterol, and triglyceride (TG) 
levels were measured with original kits using an Abbott-Aeroset 
autoanalyzer (Chicago, IL, USA). Serum levels of FSH, LH, insulin 
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were measured by microparticle enzyme immunoassay method 
(MEIA) in an AXSYM autoanalyzer. Serum total testosterone 
levels were measured by solid-phase competetive chemilumi-
nescent enzyme immunassay in an Immulite 2000 autoanalyzer 
using BIODPC reagents. 
Renal Doppler Ultrasonography
All patients with polycystic overian syndrome and healthy 
control subjects were examined by B-mode and duplex Dop-
pler ultrasound using a commercially avaliable colour doppler 
scanner (Sonoline Antares, Siemens, Germany) with a 5 MHz 
convex probe. All examinations were performed with the pa-
tient in the fasting state after 30 minutes of rest. Both kidneys 
were scanned in all women in the lateral decubitus position. 
All examinations were performed by the same radiologist to 
avoid interobserver variability. Cortical thickness and long axis 
of kidney were meausured and parenchyma echogenicity was 
determined. 
Doppler spectra were obtained from the arcuate arteries at the 
corticomedullary junction. The Doppler angle was maintaned 
between 30 and 60 degrees to correct for the angle between 
the axis of the beam and the vessels. At least three resistive 
index ( RI) measurements were obtained in the lower pole, mid-
portion, and upper pole, then were averaged for each kidney at 
each session. The peak systolic velocity and resistive index ( 
RI) of both main renal arteries and the peak venous flow signal 
and least flow signal of both main renal veins were calculated. 
Cortical thickness, echogenicity , and intrarenal RI values, peak 
systolic velocity and RI values of the main renal artery, peak 
venous velocity and least venous velocity were recorded in each 
of the kidney in all patients with polycystic overian syndrome 
and healthy control subjects. Venous impedance index was cal-
culated as: (peak venous velocity- least venous velocity) / peak 
venous velocity .
Statistics
Statistical analysis were performed using SPSS 10.0 (SPSS for 
Windows 10.0; Chicago, IL, USA). Groups were compared us-
ing student t test. When parametric tests were not appropriate, 
Mann-Whitney U test was used. For the analysis of categori-
cal variables, we used the χ2 test and Fisher exact test, where 
available. Pearson’s correlation analysis was used to test uni-
variate relations. A p value <0.05 was considered significant.
Results
There was not significant difference between PCOS and control 
groups in terms of age, body mass index (BMI), waist-to-hip 
ratio (WHR), systolic and diastolic blood pressure (BP) [Table 
1]. The rate of hirsutism/acne, oligomenorrhea, impaired glu-
cose tolerance (IGT) and serum LH level and ovarian AFC in 
second day of cycle and serum total testorone were higher in 
with PCOS women than control healty women [Table 2]. 
1- Kidneys size: There was no difference between the right 
renal length (RRL) (107,1mm) and the left renal length (LRL) 
(106,9mm). Both kidneys length were slightly lower (statisti-
cally nonsignificant) in PCOS women [Table 3]. Both lengths 
correlated significantly and positively with BMI, WHR, fasting 
glucose, insulin, HOMA, LDL. 
2- Kidneys parenchymal thickness: Right and left kidney paren-
chymal thickness had similar patterns (respectivelly 13,84mm 
and 14,04mm). Both kidney parenchymal thickness also had no 
difference between two groups (Table 3). Both kidney parenchy-
mal thickness correlated significantly and positively with BMI, 
fasting glucose, insulin, HOMA, trigliseride.
3- Kidney arteries PSV: There was no difference between right 
and left renal arteries PSV (respectivelly 94,8cm/sec; 95,7cm/
sec p>,05). In women with PCOS, average renal PSV and left 
renal PSV were significantly lower than healty women (respec-
tively p=,001, p=,015) (Table 3). PSV correlated significantly and 
negatively with insulin, HOMA [Table 4].
3- Kidney arteries RI: There was no difference between right 
and left renal arteries RI (respectivelly 0,636; 0,629 : p>,05). In 
women with PCOS, average renal RI was slightly higher than 
healty women (statistically unsignificant) (p=,062). RI correlated 
significantly and positively with insulin and HOMA, negatively 
HDL (Table 4). Mean RI of upper, middle, bottom lobar renal 
arteries were not difference between two groups.
4- Venous impedance (VI) index: Right and left kidney veins had 
different impedance index (respectivelly 0,48; 0,41 p<,05). In 
women with PCOS, average renal VI index and left renal VI in-
Table1. Anthropometrical characteristics of PCOS and control group.
characteristics PCOS group 
N:40
Mean ±SD
Control group 
N:36
Mean ±SD
P value
Age (year) 26,43±4,76 28,034,03± ,117
BMI 28,93±6,73 29,03±3,56 ,855
Waist Circumference (cm) 84,85±13,81 82,83±7,04 ,635
Hip Circumference (cm) 108,35±14,50 107,53±9,43 ,868
WHR ,78±,04 ,77±,03 ,768
Systolic BP (mmHg) 120,67±10,21 118,89±8,45 ,687
Diastolic BP (mmHg) 81,56±4,59 79,34±5,13 ,876
Legend 1: BMI: Body mass index, WHR: Waist-to- hip ratio, BP: Blood pressure
Table 2. Clinic and biochemical characteristics of PCOS and control group
Characteristics PCOS group 
N:40 Mean ±SD
Control group 
N:36 Mean ±SD
P value
Fasting Glucose (mg/dl) 93,93±6,02 91,42±6,69 ,092
Insulin (μU/ml) 10,72±4,36 9,29±3,57 ,122
HOMA index 2,45±,97 2,08±,82 ,077
Total Testosterone (ng/ml) ,738±,30 ,54±,16 ,001
Free Testosterone (pg/ml) 1,58±,76 1,27±,68 ,056
HDL (mg/dl) 47,35±8,96 51,97±7,71 ,018
LDL (mg/dl) 108,53±24,68 120,06±18,7 ,024
Triglycerides (mg/dl) 116,65±59,34 109,47±37,61 ,527
TSH (μU/ml) 3,03±4,68 1,81±,50 ,110
LH (mIU/ml) 8,80±5,71 4,70±1,11 ,000
CRP (mg/dl) 3,68±2,31 2,85±2,02 ,115
AFC 54,10±25,54 18,19±5,94 ,000
Hirsutism or acne (%) 34,2 5,3 ,000
Oligoamenorrhea (%) 44,7 6,6 ,000
IGT (%) 2,6 9,2 ,082
Legend 2: Student t test, HOMA index, homeostasis model assessment index:  HDL: High-
density lipoprotein,  LDL: Low-density lipoprotein,  TSH: thyroid-stimulating hormone, LH: 
(in second day of cycle), CRP: c-reactive protein,  AFC: Antral follicle count (in second day of 
cycle), IGT: Impaired glucose tolerance.
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dex were significantly higher than healty women (respectively 
p=,009, p=,007) [Table 3].
Discussion
PCOS is a metabolic disorder which have contraversial defini-
tion yet. PCOS may cover to the differ extends of the glucose 
and lipid metabolism abnormalities. Obesity is common in PCOS 
and affects between 30–70% of women depending on the set-
ting of the study and the ethnical background of the subjects. In 
Western society, incidence and prevalans of overweight/obesity 
increase recently [12]
Our population also have included large amount overweight 
women who have average BMI was 29. The overweight/obesity 
lead to impaired glycemic control and insulin resistance.
There is evidence concerning the relationship between renal 
dysfunction and cardiovascular risk in non-diabetic patients. 
Even minor renal dysfunction causes a dramatic increase in car-
diovascular risk. PCOS not only is a reproductive endocrinopa-
thy but, like the metabolic syndrome, is associated with long-
term health risks including insulin resistance, diabetes mellitus, 
dyslipidemia, hypertension, and premature atherosclerosis [13].
Based on the prevalence of these risk factors, PCOS patients 
have an estimated 4–11-fold increased risk for coronary heart 
disease[14] . Epidemiologic studies have documented that dia-
betes and hypertension are the major risk factors for the devel-
opment and progression of chronic kidney disease (CKD)[15,16]. 
Chen et al suggested that the insulin resistance and concomi-
tant hyperinsulinemia are presented in CKD patients without 
clinical diabetes [17]. They also suggest that even mildly el-
evated blood pressure (130/85 mm Hg) or serum glucose levels 
(110 mg/dL) are associated with an increased risk for chronic 
kidney disease and microalbuminuria [18] . 
In recent years, advanced ultrasonography transducers have led 
to inreased tissue information and spatial and contrast resolu-
tion. Consequently, these improvements simplified to evaluation 
of renal anatomic details as dimension, thickness and echo-
genicity of the renal cortex. These morphologic parameters are 
important, because ultrasonography shows findings of irrevers-
ible renal parenchymal disease as decrease in renal size, pa-
renchymal atrophy, sclerosis and fibrosis [7]. In addition, it can 
help to assess prognosis and avoid unnecessary diagnostic or 
therapeutic procedures. Especially, this radiologic method show 
a smaller kidney with parenchymal atrophy is diabetic nephrop-
athy, the leading cause of chronic and end-stage renal failure in 
developed countries in recent years [19]. 
To our knowledge, there is no study investigating renal size 
measurements in women with PCOS. Whereas, the studies 
related to the normal ultrasonographic measurements of the 
kidney in adult volunteers has been reported by Emamian SA 
et al [20]. They demonstrated that renal dimensions and paren-
chymal volume were correlated with age, height, weight, body 
mass index, and total body area. Median renal lengths were 
11.2 cm on the left side and 10.9 cm on the right side. Renal 
size decreased with age, almost entirely because of parenchy-
mal reduction. Renal length decreased with age and the rate 
of decline accelerates alter 60 years of age. Renal volume cor-
related best with total body area. Renal length correlated best 
with body height [21]. It was known that there is a trend both 
for the right and left kidney longitudinal lengths to increase un-
til reptoductive age . 
Enamian et al demonstrated that renal size unchange in normal 
situation. In our study, renal size, cortical echogenicity and pa-
renchymal thickness of all kidneys were normal. There was no 
difference between the right renal length (RRL) and the left re-
nal length (LRL) . Both right and left kidney length were slightly 
lower (statistically nonsignificant) in women with PCOS (Table 
3).
Color Doppler ultrasonography is noninvasive method for as-
sesment renal vascular function. It meaures blood flow velocity 
in the renal circulation within small parenchymal arteries. The 
resistive index ( RI) shows vascular resistance and increase of 
this value demonstrates diseases of tubulointerstitial or vas-
cular system. As is known, RI is an age-dependent parameter. 
Bude et al showed that RI in patents older than 60 years tends 
to be higher than in younger adults [22]. 
The peak systolic velocity (PSV) is direct proportional with flow 
volume ( left ventricle beat volume). In addition, PSV is inversely 
Table 3. Comparison of  arterial and venous blood flow parameters and renal 
biometric measurements right and left kidney in PCOS and control groups.
 PCOS group 
N:40
 Mean±SD
Control group
 N:36 
Mean±SD
95%
Confidence
Interval of
the Difference
P value
Right Renal 
Length (mm)
106,40±7,11 107,94±8,07 -1,95- 5,04 ,382
Left Renal 
Length (mm)
106,88±9,75 107,06±8,02 -3,89- 4,25 ,930
Mean Renal 
Length (mm)
106,63±7,7 107,50±7,05 -4,2-  2,5 ,613
Right Paren-
chyma Thickness 
(mm)
13,58±1,85 14,14±2,01 -,32- 1,45 ,210
Left Parenchyma 
Thickness (mm)
14,38±2,33 13,67±1,62 -1,62- ,20 ,127
Mean Paren-
chyma Thickness 
(mm)
13,97±1,4 13,90±1,6 -,63-   ,78 ,203
Right Renal RI ,64±,06 ,62±,05 -,048- ,003 ,089
Left Renal RI ,64±,05 ,61±,05 -,044- ,001 ,067
Mean Renal RI ,64±,04 ,62±,04 -,00049-  ,040 ,062
Right Renal PSV 
(cm/sec)
92,85±28,12 97,00±23,00 -7,55 -15,85 ,482
Left Renal PSV 
(cm/sec)
87,40±21,71 105,11±23,25 7,38 - 28,03 ,001
Mean PSV (cm/
sec)
90,12±20,21 101,05±17,80 -19,6- -2,24 ,015
Mean Upper 
Lobar Renal 
Artery RI
,58±,05 ,60±,03 -,038-  ,003 ,106
Mean Middle 
Lobar Renal 
Artery RI 
,61±,05 ,62±,04 -,025-  ,018 ,770
Mean Bottom 
Lobar Renal 
Artery RI
,62±,04 ,62±,03 -,021-  ,017 ,855
Right Venous 
Impedance Index
,50±,17 ,47±,15 -,106- ,043 ,410
Left Venous Im-
pedance İndex
,46±,17 ,36±,15 -,180-  -,308 ,007
Mean Venous 
Impedance Index
,48±,12 ,41±,09 ,017- ,11 ,009
Legend 3: RI: Resistive index, PSV : Peak systolic velocity,
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proportional with vascular diameter and elasticity of blood ves-
sel wall. The normal frequency spectrum presents the typical 
form of a flow pulse, with low subsequent vascular resistance. 
In adults, the normal PSV is average 120 ±12 cm/sec (100–180 
cm/sec) and the end-diastolic flow velocity is 20-50 cm/ s [8,23]. 
The kidneys offer a low resistance vascular bed, thus the Dop-
pler spectral waveform from the normal kidney is that of a 
constant forward diastolic flow. In renal parenchymal disease, 
there is increase vascular resistance which in turn causes a de-
crease in the diastolic flow component and increased pulsatility 
of the Doppler spectral waveform. Parenchymal diastolic flow 
velocities less than 20 per cent of the peak systolic velocity 
are consistent with renal parenchymal disease. In renal artery 
stenosis, the PSV shows an increase of more than 150cm/sec. 
When vascular resistance is low, peak systolic velocity and peak 
flow volume increase with increasing blood pressure. Spon-
taneous variations in subject’s systolic blood pressure were 
positively correlated with peak systolic volume and peak flow 
volume. Low resistance flow is blood pressure dependent [24]. 
Decreased PSV could show inceased vascular resistance. We 
found the lower PSV in PCOS women. 
Color doppler ultrasound shows renal vascular resistance using 
RI value, which corresponds to peak systolic velocity minus end-
diastolic velocity divided by peak systolic velocity. The RI values 
are calculated in the segmental, interlobar, and arcuate arter-
ies, these values are normally below 0.70 except significantly 
higher in elderly persons and in those younger than 6 years [24]. 
The effects of variation in vessel angulation and size are nul-
lified in the calculation of these indexes [25]. Various abnor-
mal waveforms may be compared by calculating the RI and PI. 
Physiologic events that alter vascular resistance and thus affect 
waveforms include exercise, changes in gravity orientation and 
stress level, and digestion [25].
Changes in the intrarenal arterial RI values are associated with 
diseases as urinary obstruction, various renal disorders, renal 
vascular disease, renal scarring . The RI provides information 
about arterial impedance. The pressure differential between the 
systole and diastole was shown to be a major factor influencing 
RI, along with the vascular compliance and the cross-sectional 
area of the downstream vascular bed [26]. 
In our study, there was no difference between RI values of right 
and left renal arteries (respectivelly 0,636; 0,629 : p>,05). In 
women with PCOS, average renal RI was slightly higher than 
healty women (statistically unsignificant) (p=,062). RI correlated 
Table 4. Corelations of  renal blood flow parameters with biochemical and clinic characteristics in all patients.
 Mean 
Renal 
Length
Mean 
Parenchyma
Thickness
Mean  Renal
 Artery PSV
Mean Re-
nal
Artery RI
Mean Upper 
Lobar Renal 
Artery RI
Mean Middle 
Lobar Renal 
Artery RI
Mean Bottom 
Lobar Renal 
Artery RI
Mean Venous 
Impedance 
Index
BMI
 
r ,365(**) ,378(**) -,063 ,150 ,185 ,104 ,075 ,053
p ,001 ,001 ,589 ,197 ,110 ,372 ,521 ,651
WHR
 
r ,292(*) ,047 ,029 -,149 -,293(*) -,341(**) -,127 -,035
p ,010 ,687 ,803 ,198 ,010 ,003 ,275 ,762
Fasting Glucose (mg/dl)
r ,316(**) ,281(*) ,032 -,054 -,053 ,021 ,267(*) ,022
p ,005 ,014 ,784 ,641 ,646 ,857 ,020 ,850
Insulin (μU/ml) 
 
r ,214 ,239(*) -,375(**) ,508(**) ,252(*) ,278(*) ,304(**) ,139
p ,063 ,037 ,001 ,000 ,028 ,015 ,008 ,231
HOMA index
 
r ,269(*) ,282(*) -,355(**) ,475(**) ,230(*) ,251(*) ,325(**) ,149
p ,019 ,014 ,002 ,000 ,046 ,029 ,004 ,200
HDL (mg/dl)
 
r -,079 -,015 ,053 -,290(*) -,298(**) -,168 -,090 -,033
p ,498 ,897 ,650 ,011 ,009 ,147 ,440 ,777
LDL (mg/dl)
 
r ,483(**) ,012 ,094 ,113 ,154 ,113 ,264(*) -,037
p ,000 ,920 ,420 ,330 ,183 ,332 ,021 ,752
Triglycerides (mg/dl)
r ,170 ,191 ,087 -,057 ,066 ,128 ,147 -,179
p ,141 ,098 ,453 ,622 ,569 ,270 ,206 ,122
Mean Renal Length
r ,477(**) ,179 ,087 ,035 ,178 ,279(*) ,059
p ,000 ,121 ,455 ,767 ,125 ,015 ,610
Mean Parenchyma Thickness
r 1 ,111 -,024 ,069 ,200 ,068 -,064
p  ,341 ,834 ,554 ,083 ,560 ,581
Mean Renal Artery PSV
r 1 -,400(**) -,047 -,108 -,141 -,502(**)
p ,000 ,690 ,353 ,225 ,000
Mean Renal Artery RI
r 1 ,518(**) ,396(**) ,349(**) ,200
p  ,000 ,000 ,002 ,084
Mean Upper Lobar Renal Artery RI
r 1 ,612(**) ,439(**) ,034
p ,000 ,000 ,772
Mean Middle Lobar Renal Artery RI
r 1 ,674(**) ,148
p  ,000 ,201
Mean Bottom Lobar Renal Artery RI
r 1 ,237(*)
p  ,039
Legend: RI: Resistive index, HOMA index, homeostasis model assessment index:  HDL: High-density lipoprotein,  LDL: Low-density lipoprotein.
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significantly and positively with insulin and HOMA, negatively 
HDL (Table 4). Mean RI of upper, middle, bottom lobar renal 
arteries were not difference between two groups. We thought 
that higher RI values in women with PCOS might be indicate 
early period of atherosclerosis . Especially, relationship be-
tween RI and insulin values may be important to determine mild 
vascular changes. 
The average flow velocity (Vmean) values of renal vein are given 
in the literature as 10-20 cm/ s. The flow in the renal veins is 
generally continuous, but mild fluctuations may be seen as a 
reflection of respiration and right atrial contraction [27]. 
The flow pattern in intrarenal veins depends on renal paren-
chymal histology and cardiac physiology. The intrarenal venous 
impedance index obtained by Doppler ultrasound is related to 
compliance in vein, and can be helpful in the assessment of 
renal parenchymal compliance.
renal hemodynamics. Microalbuminuria and reduced glomerular 
filtration rate (GFR) are two different aspects of renal dysfunc-
tion. It is known that renal hemodynamics associated with mi-
croalbuminuria and reduced GFR [6]. We did not investigated 
to linked with renal hemodynamics and renal biometry in this 
study. 
Potential limitations of our study should be noted. First, the 
cross-sectional study design makes it difficult to infer causality 
between the PCOS and risk for chronic kidney disease. Second, 
study population were heterogen in terms of age, BMI (both 
obes and lean), having insulin resistance. If it is created a pa-
tient subgroup with obesity and insulin resistance patient, It 
could obtain whether causes of hemodynamic alterations are 
PCOS or insülin resistance. It was suggested by Chen that the 
metabolic syndrome and insulin resistance might be an impor-
tant factor in the cause of chronic kidney disease and microal-
buminuria [18]. 
Third, in our study, it is indeterminate patient to what extent 
period with PCOS. As renal and vascular effect consist during 
long term period, our findings may be weak than expected re-
ally. Fourth, the disadvantages of renal doppler ultrasound in-
clude decreased reliability in a patient who is not fasting and/
or is obese, a high level of operator dependence, and poor de-
tail resolution. But, renal doppler ultrasound examination was 
done by one radiologist for decrease of these disadvantages. 
Another limitation of our study is that we did not investigate 
the waveform in the inferior vena cava which might likely be 
altered and affect the intrarenal venous waveform. 
In conclude, we suggested that there was alterations especially 
kidney blood flow in normotensive reproductive age women 
with PCOS. This findings may explain to results of long term 
renal and vascular complications of PCOS. However, a further 
study with a wider selected subgroups is required.
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